Navigation Links
Neurocrine Biosciences Announces Successful Phase IIa Clinical Trial for VMAT2 Inhibitor
Date:4/5/2011

inances in general, as well as risks and uncertainties associated with the Company's VMAT2 program and Company overall. Specifically, the risks and uncertainties the Company faces with respect to the Company's VMAT2 program include, but are not limited to; risk that NBI-98854 will not proceed to later stage clinical trials and risk that the Company's clinical trials will fail to demonstrate that NBI-98854 is safe and effective. With respect to its pipeline overall, the Company faces risk that it will be unable to raise additional funding required to complete development of all of its product candidates; risk relating to the Company's dependence on contract manufacturers for clinical drug supply; risks associated with the Company's dependence on corporate partners for development, commercial manufacturing and marketing and sales activities for the Company's partnered programs; uncertainties relating to patent protection and intellectual property rights of third parties; risks and uncertainties relating to competitive products and technological changes that may limit demand for the Company's products; and the other risks described in the Company's report on Form 10-K for the year ended December 31, 2010. Neurocrine undertakes no obligation to update the statements contained in this press release after the date hereof.


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Neurocrine Biosciences to Present at the Cowen & Co. 31st Annual Health Care Conference
2. Neurocrine Biosciences Reports Fourth Quarter and Year End 2010 Results
3. Neurocrine Biosciences Announces Conference Call and Webcast to Report Third Quarter 2010 Financial Results
4. Abbott and Neurocrine Announce Global Agreement to Develop and Commercialize Elagolix for the Treatment of Endometriosis
5. Neurocrine Biosciences Announces Conference Call and Webcast on Worldwide Agreement With Abbott on Elagolix
6. Neurocrine Biosciences to Present at the Jefferies 2010 Global Life Sciences Conference and the 9th Annual Needham Healthcare Conference
7. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2010 Financial Results
8. Neurocrine Biosciences, Inc. Announces Exercise of Over-Allotment Option for Common Stock Offering
9. Neurocrine Biosciences to Present at the Roth 22nd Annual OC Growth Conference
10. Neurocrine Biosciences Announces the Appointment of William H. Rastetter to Its Board of Directors
11. Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2014)... Aug. 18, 2014   Sterne, Kessler, Goldstein & ... Washington, DC , announced today that ... Review (IPR) with the U.S. Patent and Trademark ... of BioReference Laboratories, Inc. (Nasdaq: BRLI).  These IPR petitions ... by Myriad Genetics, Inc. These patents have been asserted ...
(Date:8/18/2014)... 2014 According to a ... "Life Science Reagents Market(Products- PCR Reagent Kits, Cell ... Diagnostic Reagents and Others; End Users- Commercial and ... and Forensic Laboratories)- Global Industry Analysis, Size, Share, ... global life science reagents market was valued at ...
(Date:8/18/2014)... Aug. 18, 2014 Dyadic International, Inc. ... patented and proprietary technologies are used to develop, ... the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme ... Registration Statement on Form 10 with the U.S. ... Logo - http://photos.prnewswire.com/prnh/20110621/CL06708LOGO ...
(Date:8/16/2014)... Firms in the Scientific ... advisory services to businesses, government bodies and nonprofit ... are highly diverse as operators assist a range ... geological and geophysical consulting services to risk management ... five years, the recovery of the Canadian economy ...
Breaking Biology Technology:Sterne Kessler Files 11 IPR Petitions On Behalf Of GeneDx, Inc., Subsidiary Of BioReference Laboratories, Inc. 2Sterne Kessler Files 11 IPR Petitions On Behalf Of GeneDx, Inc., Subsidiary Of BioReference Laboratories, Inc. 3Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 2Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 3Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 4Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 5Dyadic International Files Form 10 Registration Statement 2Dyadic International Files Form 10 Registration Statement 3Dyadic International Files Form 10 Registration Statement 4Scientific and Economic Consulting in Canada Industry Market Research Report Now Available from IBISWorld 2Scientific and Economic Consulting in Canada Industry Market Research Report Now Available from IBISWorld 3
... Vectors for Functional Analysis in Yeast ,,, ... Quinn Lu Tanya Hosfield ,Stratagene ... vectors to express,and functionally analyze eukaryotic genes in ... vectors contains one of four different yeast,selective markers ...
... custom molecular beacon synthesis assists in detecting SNPs,quickly and easily ... Fei Bao , University of ... We used Stratagenes custom molecular beacons ff, ... of chromosome,10q25.1 and showed clear discrimination among the different genotypes ...
... on a convenient single-slide format , ... Complete View tissue array,slides offer ... optimized,tissue fixation and processing procedures that preserve ... reactivity. This innovative product,line consists of murine ...
Cached Biology Technology:Epitope-Tagging Vectors for Functional Analysis in Yeast 2Epitope-Tagging Vectors for Functional Analysis in Yeast 3Epitope-Tagging Vectors for Functional Analysis in Yeast 4Epitope-Tagging Vectors for Functional Analysis in Yeast 5Epitope-Tagging Vectors for Functional Analysis in Yeast 6Genotyping Single Nucleotide Polymorphisms with Molecular Beacons 2Genotyping Single Nucleotide Polymorphisms with Molecular Beacons 3Genotyping Single Nucleotide Polymorphisms with Molecular Beacons 4Genotyping Single Nucleotide Polymorphisms with Molecular Beacons 5Genotyping Single Nucleotide Polymorphisms with Molecular Beacons 6Innovative Tissue Array Technology for High-Throughput Screening of Gene,Expression 2Innovative Tissue Array Technology for High-Throughput Screening of Gene,Expression 3Innovative Tissue Array Technology for High-Throughput Screening of Gene,Expression 4Innovative Tissue Array Technology for High-Throughput Screening of Gene,Expression 5
(Date:8/20/2014)... are poor experience higher cortisol levels in pregnancy and ... stress hormone, putting them at greater risk for ... research from the University of Colorado Denver. , The ... of Human Biology , is the first to measure ... socioeconomic status of their mothers during pregnancy. , "There ...
(Date:8/20/2014)... NEW YORK and POINT ROBERTS, Washington ... Will Biometrics Play a Key Role in Addressing Security Concerns ... http://www.investorideas.com ), a global news source covering leading sectors including ... digital wallet market. Jason Peaslee , Managing ... Biometrics Institute and Gino Pereira , CEO of NXT-ID, ...
(Date:8/19/2014)... German . ... a large amount of electricity is to be produced with ... to be stored during productive periods so that these fluctuations ... from adequate for the purpose. Science and industry are therefore ... battery systems that used to be too expensive or unsophisticated ...
Breaking Biology News(10 mins):CU Denver researcher shows economic disparities impact infant health 2Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 2Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 3Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 4Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 5Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 6Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 7Asian inventions dominate energy storage systems 2Asian inventions dominate energy storage systems 3
... chemistry researchers moved closer to what is considered the ... the first-ever direct detection of biological particles within ice ... Ph.D. student of atmospheric chemistry Professor Kim Prather, who ... well as the Department of Chemistry and Biochemistry at ...
... a professor of medicine, physiology and biophysics at the ... understanding of vitamin D and its role in disease ... for Health Research. The prize was presented at ... the Linus Pauling Institute at Oregon State University. It ...
... 15, 2009 The research group of Dr. Frdric Charron, ... (IRCM), has made a discovery which could help treat spinal ... published in the current issue of the prestigious scientific journal ... Steves Morin, all at the IRCM, are listed as co-authors. ...
Cached Biology News:UCSD researchers make first direct observations of biological particles in high-altitude ice clouds 2UCSD researchers make first direct observations of biological particles in high-altitude ice clouds 3Vitamin D expert receives Linus Pauling Prize for Health Research 2Identification of a key molecular pathway required for brain neural circuit formation 2
...
... siSolutions siRNA Custom Synthesis Service ... duplex RNA to knockdown any ... (19 RNA base pairs with ... 27-mers, or other lengths of ...
... Rabbit Antibody to CRF ... the ovine CRF sequence that ... and fibres are found in ... rat brain in colchicine treated ...
...
Biology Products: